A COMPARATIVE-STUDY OF SOME PHYSICOCHEMICAL PROPERTIES OF HUMAN-SERUM ALBUMIN SAMPLES FROM DIFFERENT SOURCES .2. THE CHARACTERISTICS OF THE N-B TRANSITION AND THE BINDING BEHAVIOR WITH REGARD TO WARFARIN AND DIAZEPAM

被引：21
作者：
DROGE, JHM
WILTING, J
JANSSEN, LHM
机构：
来源：
BIOCHEMICAL PHARMACOLOGY | 1982年 / 31卷 / 23期
关键词：
D O I：
10.1016/0006-2952(82)90293-3
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：3781 / 3786
页数：6
相关论文
共 40 条
[21]   HUMAN-SERUM ALBUMIN AS A SILENT RECEPTOR FOR DRUGS AND ENDOGENOUS SUBSTANCES [J].
MULLER, WE ;
WOLLERT, U .
PHARMACOLOGY, 1979, 19 (02) :59-67
[22]   REVERSIBLE SULFHYDRYL-CATALYZED STRUCTURAL ALTERATION OF BOVINE MERCAPTALBUMIN [J].
NIKKEL, HJ ;
FOSTER, JF .
BIOCHEMISTRY, 1971, 10 (24) :4479-&
[23]  
PIAFSKY KM, 1977, CLIN PHARMACOL THER, V22, P545
[24]   ON NATURE OF ALLOSTERIC TRANSITIONS - IMPLICATIONS OF NON-EXCLUSIVE LIGAND BINDING [J].
RUBIN, MM ;
CHANGEUX, JP .
JOURNAL OF MOLECULAR BIOLOGY, 1966, 21 (02) :265-&
[25]   BINDING OF CALCIUM IONS TO SERUM ALBUMIN [J].
SAROFF, HA ;
LEWIS, MS .
JOURNAL OF PHYSICAL CHEMISTRY, 1963, 67 (06) :1211-&
[26]  
SJOHOLM I, 1980, ACTA PHARM SUEC, V17, P76
[27]  
SJOHOLM I, 1979, MOL PHARMACOL, V16, P767
[28]   PROTEIN-BINDING OF DRUGS IN UREMIC AND NORMAL SERUM - ROLE OF ENDOGENOUS BINDING INHIBITORS [J].
SJOHOLM, I ;
KOBER, A ;
ODARCEDERLOF, I ;
BORGA, O .
BIOCHEMICAL PHARMACOLOGY, 1976, 25 (10) :1205-1213
[29]  
SOGAMI M, 1963, J BIOL CHEM, V238, P2245
[30]  
SPECTOR AA, 1975, J LIPID RES, V16, P165
1234